1. Home
  2. CHCT vs CGEM Comparison

CHCT vs CGEM Comparison

Compare CHCT & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHCT
  • CGEM
  • Stock Information
  • Founded
  • CHCT 2014
  • CGEM 2016
  • Country
  • CHCT United States
  • CGEM United States
  • Employees
  • CHCT N/A
  • CGEM N/A
  • Industry
  • CHCT Real Estate Investment Trusts
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHCT Real Estate
  • CGEM Health Care
  • Exchange
  • CHCT Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • CHCT 422.2M
  • CGEM 490.3M
  • IPO Year
  • CHCT 2015
  • CGEM 2021
  • Fundamental
  • Price
  • CHCT $16.34
  • CGEM $8.65
  • Analyst Decision
  • CHCT Buy
  • CGEM Strong Buy
  • Analyst Count
  • CHCT 4
  • CGEM 4
  • Target Price
  • CHCT $21.00
  • CGEM $32.00
  • AVG Volume (30 Days)
  • CHCT 196.0K
  • CGEM 450.4K
  • Earning Date
  • CHCT 07-29-2025
  • CGEM 05-08-2025
  • Dividend Yield
  • CHCT 11.41%
  • CGEM N/A
  • EPS Growth
  • CHCT N/A
  • CGEM N/A
  • EPS
  • CHCT N/A
  • CGEM N/A
  • Revenue
  • CHCT $116,531,000.00
  • CGEM N/A
  • Revenue This Year
  • CHCT $7.14
  • CGEM N/A
  • Revenue Next Year
  • CHCT $7.04
  • CGEM N/A
  • P/E Ratio
  • CHCT N/A
  • CGEM N/A
  • Revenue Growth
  • CHCT 1.33
  • CGEM N/A
  • 52 Week Low
  • CHCT $14.76
  • CGEM $6.85
  • 52 Week High
  • CHCT $27.62
  • CGEM $24.76
  • Technical
  • Relative Strength Index (RSI)
  • CHCT 48.18
  • CGEM 62.37
  • Support Level
  • CHCT $15.62
  • CGEM $7.73
  • Resistance Level
  • CHCT $16.85
  • CGEM $8.00
  • Average True Range (ATR)
  • CHCT 0.39
  • CGEM 0.51
  • MACD
  • CHCT 0.02
  • CGEM 0.12
  • Stochastic Oscillator
  • CHCT 54.96
  • CGEM 89.92

About CHCT Community Healthcare Trust Incorporated

Community Healthcare Trust Inc is an integrated healthcare real estate company in the United States. The company owns and acquires, or finances, real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers in non-urban markets. The company derives majority of its revenues from its real estate property and mortgage notes portfolio. The company's rental and mortgage interest income is recognized based on contractual arrangements with its tenants and borrowers.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: